TrialArthritis & rheumatology (Hoboken, N.J.)2018

Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus: Results of a Twenty-Four-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Phase IIb Study.

Joan T Merrill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.